Industry: Pharmaceuticals, Biotechnology
Dynamis Therapeutics, Inc. is a privately held technology-based company focused on developing cosmetic and therapeutic products to treat the effects of aging by lowering the levels of 3-deoxyglucosone, an adversely reactive molecule found in skin and kidney. Dynamis Therapeutics, Inc. expects to launch an anti aging cosmetic face cream in 2005 and enter into a strategic alliance with a major pharmaceutical company in 2006 for the development of a drug to treat the accelerated aging diseases associated with diabetes and elevated 3DG levels, such as heart and kidney disease, neuropathy and blindness. Dynamis Therapeutics, Inc. is also working on controlling Scleroderma, a disease that it believes is also associated with aberrant regulation of 3DG. ( www.dynamis-therapeutics.com )
Dynamis Therapeutics Inc
4Th Floor Research 8360 Old York Rd.
Elkins Park, Pennsylvania 19027-1598
USA
Tel: (215) 780-1482
Fax: (215) 780-1464